Metraipolis › archive › dc_17d6ff0342bc

Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies — Europe PMC PMID:41009806

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41009806
DOI
10.3390/ijms26189244
License (as archived)
solo-consultazione
Archived
2026-11-09T20:17:22.623Z
SHA-256 of the archived text
b7c202f3026598c61edb0d883c6eb2e9cc66cb5d7e1881ff3c4e4facfd9d9a1d
Stable URL of this page
https://metraipolis.com/documento/dc_17d6ff0342bc

How to cite

Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies — Europe PMC PMID:41009806 — Europe PMC (en), https://europepmc.org/article/MED/41009806 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17d6ff0342bc (Metraipolis archive dc_17d6ff0342bc, sha256 b7c202f3026598c61edb0d883c6eb2e9cc66cb5d7e1881ff3c4e4facfd9d9a1d)
BibTeX
@misc{dc17d6ff0342bc,
  title = {Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies — Europe PMC PMID:41009806},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41009806},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17d6ff0342bc; sha256 b7c202f3026598c61edb0d883c6eb2e9cc66cb5d7e1881ff3c4e4facfd9d9a1d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41009806. Agents can read the archived copy with the MCP tool read_document.